Product
OCA + BZF
1 clinical trial
1 indication
Indication
Primary Biliary CholangitisClinical trial
A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects With Primary Biliary CholangitisStatus: Not yet recruiting, Estimated PCD: 2025-01-01